Repeat Percutaneous Radiofrequency Ablation of T1 Renal Cell Carcinomas is Safe in Patients with Von Hippel–Lindau Disease

PURPOSE: Patients with Von Hippel-Lindau disease often develop multifocal, metachronous renal cell carcinomas which require therapy. The purpose of this retrospective single-center study is to evaluate the outcomes of radiofrequency ablation (RFA) in the treatment of renal cell carcinomas in patient...

Descripción completa

Detalles Bibliográficos
Autores principales: Wessendorf, Joel, König, Alexander, Heers, Hendrik, Mahnken, Andreas H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2021
Materias:
Short Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8626382/
https://www.ncbi.nlm.nih.gov/pubmed/34414496
http://dx.doi.org/10.1007/s00270-021-02935-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8626382/
https://www.ncbi.nlm.nih.gov/pubmed/34414496
http://dx.doi.org/10.1007/s00270-021-02935-w

Ejemplares similares